Angiogenesis and immunological markers in non-small celll lung cancer
- Prosjektnummer
- SFP1094-13
- Ansvarlig person
- Tom Dønnem
- Institusjon
- Universitetssykehuset Nord-Norge HF
- Prosjektkategori
- Ph.d.-stipend
- Helsekategori
- Cancer and neoplasms, Inflammatory and immune system, Respiratory
- Forskningsaktivitet
- 1. Underpinning, 7. Disease Management
Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.
Clin Lung Cancer 2017 Mar;18(2):220-233.e8. Epub 2016 okt 5
PMID: 27816392 - Inngår i doktorgradsavhandlingen
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.
Cancer Immunol Immunother 2017 Nov;66(11):1449-1461. Epub 2017 jul 13
PMID: 28707078 - Inngår i doktorgradsavhandlingen
The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort.
Oncotarget 2017 Apr 18;8(16):26789-26801.
PMID: 28460462
Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.
Ann Oncol 2016 Feb;27(2):225-32. Epub 2015 nov 16
PMID: 26578726
The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival.
Br J Cancer 2016 May 10;114(10):1145-51. Epub 2016 apr 7
PMID: 27167450
The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.
J Thorac Oncol 2016 Jun;11(6):789-800. Epub 2016 feb 1
PMID: 26845192
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer.
Oncotarget 2016 Nov 01;7(44):72184-72196.
PMID: 27708229
CD45RO(+) Memory T Lymphocytes - a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.
Neoplasia 2015 Nov;17(11):839-48.
PMID: 26678911 - Inngår i doktorgradsavhandlingen
Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis.
PLoS One 2015;10(8):e0132481. Epub 2015 aug 25
PMID: 26305218
Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.
PLoS One 2015;10(8):e0134965. Epub 2015 aug 7
PMID: 26252379
Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer.
Clin Cancer Res 2015 Jun 1;21(11):2635-43. Epub 2015 feb 13
PMID: 25680376
Immunological markers of non-small cell lung cancer
- Disputert:
- februar 2017
- Hovedveileder:
- Tom Dønnem
- Erna Elise Paulsen Doktorgradsstipendiat
- Tom Dønnem Prosjektleder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport, Helse Nord